Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24951766
&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24951766
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Circ+Res
2014 ; 115
(1
): 176-88
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
The right ventricle in pulmonary arterial hypertension: disorders of metabolism,
angiogenesis and adrenergic signaling in right ventricular failure
#MMPMID24951766
Ryan JJ
; Archer SL
Circ Res
2014[Jun]; 115
(1
): 176-88
PMID24951766
show ga
The right ventricle (RV) is the major determinant of functional state and
prognosis in pulmonary arterial hypertension. RV hypertrophy (RVH) triggered by
pressure overload is initially compensatory but often leads to RV failure.
Despite similar RV afterload and mass some patients develop adaptive RVH
(concentric with retained RV function), while others develop maladaptive RVH,
characterized by dilatation, fibrosis, and RV failure. The differentiation of
adaptive versus maladaptive RVH is imprecise, but adaptive RVH is associated with
better functional capacity and survival. At the molecular level, maladaptive RVH
displays greater impairment of angiogenesis, adrenergic signaling, and metabolism
than adaptive RVH, and these derangements often involve the left ventricle.
Clinically, maladaptive RVH is characterized by increased N-terminal pro-brain
natriuretic peptide levels, troponin release, elevated catecholamine levels, RV
dilatation, and late gadolinium enhancement on MRI, increased
(18)fluorodeoxyglucose uptake on positron emission tomography, and QTc
prolongation on the ECG. In maladaptive RVH there is reduced inotrope
responsiveness because of G-protein receptor kinase-mediated downregulation,
desensitization, and uncoupling of ?-adrenoreceptors. RV ischemia may result from
capillary rarefaction or decreased right coronary artery perfusion pressure.
Maladaptive RVH shares metabolic abnormalities with cancer including aerobic
glycolysis (resulting from a forkhead box protein O1-mediated transcriptional
upregulation of pyruvate dehydrogenase kinase), and glutaminolysis (reflecting
ischemia-induced cMyc activation). Augmentation of glucose oxidation is
beneficial in experimental RVH and can be achieved by inhibition of pyruvate
dehydrogenase kinase, fatty acid oxidation, or glutaminolysis. Therapeutic
targets in RV failure include chamber-specific abnormalities of metabolism,
angiogenesis, adrenergic signaling, and phosphodiesterase-5 expression. The
ability to restore RV function in experimental models challenges the dogma that
RV failure is irreversible without regression of pulmonary vascular disease.
|Animals
[MESH]
|Cyclic Nucleotide Phosphodiesterases, Type 5/physiology
[MESH]